Accessibility Menu
Zoono Group logo

Zoono Group(ASX) ZNO

Market CapA$19.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-63%
5 Year-92%
1 Year+53%
1 Month-9%
A$0.05
+0.00%
+0.00Today
Zoono Group last closing stock price
MetricPriceDate
Last closeAUD 0.052026-08-03
Zoono Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-9.26%AUD 0.052026-07-27
1 month-9.26%AUD 0.052026-07-03
3 month-23.44%AUD 0.062026-05-05
Year to date-37.97%AUD 0.082025-12-31
1 year+53.13%AUD 0.032025-08-01
3 year+2.08%AUD 0.052023-08-03
5 year-92.34%AUD 0.642021-08-04
Since inception-63.33%AUD 0.132017-05-09

Zoono Group Financials at a Glance

Market Cap

A$19.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$1.96M

Net Income (TTM)

-A$7.59M

EPS (TTM)

-A$0.01

P/E Ratio

-5.16

Dividend

A$0.00

Beta (Volatility)

0.22 (Low)

Price

A$0.05

Volume

0

Open

A$0.05

Previous Close

A$0.05

Daily Range

A$0.05 - A$0.05

52-Week Range

A$0.03 - A$0.18

Estimated Earnings Date

Aug 20, 2026

ZNO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zoono Group

Zoono Group Limited specializes in the innovation, development, and global distribution of antimicrobial solutions. The company serves various industries, including aviation, medical, and hospitality, with a diverse product line that includes hand cleansers and surface disinfectants.

Products and Services
  • Antimicrobial hand cleansers for personal and industrial use
  • Specialized textile applications for enhanced hygiene
  • Mold remediation treatments and surface disinfectants
Growth Outlook
  • Expanding product offerings to meet increasing global hygiene demands
  • Strategic partnerships with key industry players to enhance market reach
  • Focus on innovation to drive future revenue growth
Financial Highlights
  • Recent quarterly revenue of 451,647 AUD, showing potential for recovery
  • Trailing twelve months (TTM) revenue of 2,159,000 AUD, indicating market presence
  • Current ratio of 4.99, suggesting strong short-term financial health
Zoono Group Limited operates in the consumer defensive sector, focusing on household and personal products. Established in 1986 and headquartered in Auckland, New Zealand, the company has built a reputation for its innovative antimicrobial solutions. The recent quarterly revenue indicates a potential recovery trajectory, while the TTM revenue reflects a solid market presence. The current ratio of 4.99 suggests that Zoono is well-positioned to meet its short-term obligations, which may appeal to potential investors. The company's commitment to expanding its product offerings and forming strategic partnerships could further enhance its growth prospects in the evolving hygiene market.
AI Generated • Jul 22, 2026

Industry

Chemicals

Sector

Materials

CEO

Paul Russell Hyslop

Website

zoono.com

Headquarters

Auckland, AU 2013, NZ

ZNO Financials

Key Financial Metrics (TTM)

Gross Margin

-74.60%

Operating Margin

-328.28%

Net Income Margin

-369.36%

Return on Equity

-108.90%

Return on Capital

-90.32%

Return on Assets

-58.46%

Earnings Yield

-19.38%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$19.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

406.21M

Volume

0

Avg. Volume

82.55K

Financials (TTM)

Gross Profit

-A$1.52M

Operating Income

-A$6.63M

EBITDA

-A$6.94M

Operating Cash Flow

-A$4.22M

Capital Expenditure

A$1.45M

Free Cash Flow

-A$4.22M

Cash & ST Invst.

A$475.33K

Total Debt

A$625.70K

Zoono Group Performance Analysis

Zoono Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 8,449,839N/A
20232023-06-30AUD 3,052,911-63.9%
20242024-06-30AUD 970,642-68.2%
20252025-06-30AUD 1,140,31617.5%
Zoono Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-39.6%
Q22024-12-3077.2%
Q42025-06-30-22.6%
Q22025-12-31-9.5%
Zoono Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.05N/A
20232023-06-30AUD -0.00-97.1%
20242024-06-30AUD -0.042635.7%
20252025-06-30AUD -0.01-73.9%
Zoono Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3058.9%
Q22024-12-3058.5%
Q42025-06-30-34.7%
Q22025-12-3157.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$451.65K

-25.0%

Gross Profit

-A$63.68K

+98.0%

Gross Margin

-14.10%

N/A

Market Cap

A$19.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$9.95M

N/A

Employees

2

N/A

Net Income

-A$1.10M

+80.0%

EBITDA

-A$932.52K

+82.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$475.33K

+276.4%

Total Debt

A$625.70K

-51.8%

Accounts Receivable

A$332.41K

+68.2%

Inventory

A$4.44M

-35.8%

Long Term Debt

A$515.76K

-21.9%

Short Term Debt

A$109.94K

-82.8%

Return on Assets

-58.46%

N/A

Return on Invested Capital

-63.14%

N/A

Free Cash Flow

-A$1.24M

+16.4%

Operating Cash Flow

-A$1.24M

+16.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
S66.AXStar Combo Pharma Limited
A$0.13+0.00%
HCT.AXHolista Colltech Limited
A$0.07-16.25%
AAP.AXAustralian Agricultural Projects Ltd
A$0.07+0.00%
NUC.AXNuchev Limited
A$0.09+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About ZNO

What is the current price of Zoono Group?

Zoono Group is trading at A$0.05 per share.

What is the 52-week range for Zoono Group?

Over the past 52 weeks, Zoono Group has traded between A$0.03 and A$0.18.

How much debt does Zoono Group have?

As of the most recent reporting period, Zoono Group reported total debt of A$544.60K.

How much cash does Zoono Group have on hand?

Zoono Group reported A$47.31K in cash and cash equivalents in its most recent financial results.

What is Zoono Group’s dividend yield?

Zoono Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.